Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedJun 27, 2026
DataAggregated Company Financials
Companies130
  • 7D2.9%
  • 3M14.7%
  • 1Y-12.0%
  • YTD-2.2%

The market has climbed 2.9% in the last 7 days, lead by the Healthcare sector with a gain of 7.0%. In contrast, the market has seen a decline of 12% over the last 12 months. Earnings are forecast to grow by 7.9% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Jun 2026DKK 4.1tDKK 2.1tDKK 245.6b16.8x16.7x2x
Mon, 25 May 2026DKK 4.0tDKK 2.0tDKK 244.6b16.5x16.4x2x
Wed, 22 Apr 2026DKK 3.8tDKK 2.0tDKK 237.2b15.6x16.1x1.9x
Fri, 20 Mar 2026DKK 3.6tDKK 2.0tDKK 237.3b15.7x15.3x1.8x
Sun, 15 Feb 2026DKK 4.1tDKK 2.0tDKK 241.9b15.9x17x2.1x
Tue, 13 Jan 2026DKK 4.4tDKK 2.0tDKK 261.0b16.4x17x2.3x
Thu, 11 Dec 2025DKK 4.0tDKK 2.0tDKK 260.9b14.6x15.5x2.1x
Sat, 08 Nov 2025DKK 3.8tDKK 2.0tDKK 259.4b14.7x14.8x2x
Mon, 06 Oct 2025DKK 4.1tDKK 1.9tDKK 287.3b15.1x14.2x2.1x
Wed, 03 Sep 2025DKK 4.0tDKK 1.9tDKK 287.7b14.9x13.9x2.1x
Fri, 01 Aug 2025DKK 3.8tDKK 1.9tDKK 263.1b15.6x14.6x2.1x
Sun, 29 Jun 2025DKK 4.4tDKK 1.9tDKK 261.8b15.4x16.7x2.4x
Tue, 27 May 2025DKK 4.5tDKK 1.9tDKK 263.9b15.8x17.2x2.4x
Thu, 24 Apr 2025DKK 4.1tDKK 1.9tDKK 259.0b14.1x16x2.2x
Sat, 22 Mar 2025DKK 4.8tDKK 1.9tDKK 260.7b15.3x18.6x2.6x
Mon, 17 Feb 2025DKK 5.0tDKK 1.9tDKK 263.5b13.7x19x2.7x
Wed, 15 Jan 2025DKK 5.1tDKK 1.8tDKK 237.4b13.6x21.4x2.8x
Fri, 13 Dec 2024DKK 6.0tDKK 1.8tDKK 237.9b14.1x25.2x3.3x
Sun, 10 Nov 2024DKK 5.8tDKK 1.8tDKK 235.8b14.4x24.8x3.2x
Tue, 08 Oct 2024DKK 6.1tDKK 1.7tDKK 180.3b15.5x34x3.5x
Thu, 05 Sep 2024DKK 6.6tDKK 1.7tDKK 180.2b15.2x36.5x3.8x
Sat, 03 Aug 2024DKK 6.4tDKK 1.7tDKK 185.5b15.3x34.6x3.7x
Mon, 01 Jul 2024DKK 7.0tDKK 1.7tDKK 184.8b15.8x37.8x4.1x
Wed, 29 May 2024DKK 6.7tDKK 1.7tDKK 184.6b15.2x36x3.9x
Fri, 26 Apr 2024DKK 6.3tDKK 1.7tDKK 191.2b14.7x32.8x3.7x
Sun, 24 Mar 2024DKK 6.5tDKK 1.7tDKK 192.3b14.6x33.7x3.8x
Tue, 20 Feb 2024DKK 6.3tDKK 1.7tDKK 190.3b13.8x33.3x3.7x
Thu, 18 Jan 2024DKK 5.7tDKK 1.8tDKK 217.1b13.4x26.4x3.2x
Sat, 16 Dec 2023DKK 5.3tDKK 1.8tDKK 216.8b13.3x24.6x3x
Mon, 13 Nov 2023DKK 5.3tDKK 1.8tDKK 218.1b12.5x24.2x3x
Wed, 11 Oct 2023DKK 5.3tDKK 1.9tDKK 284.3b13.4x18.6x2.8x
Fri, 08 Sep 2023DKK 5.4tDKK 1.9tDKK 283.1b13.4x19.1x2.9x
Sun, 06 Aug 2023DKK 4.9tDKK 1.9tDKK 274.2b13.5x17.9x2.7x
Tue, 04 Jul 2023DKK 5.1tDKK 1.9tDKK 322.2b13.9x15.7x2.6x
Price to Earnings Ratio

15.7x


Total Market Cap: DKK 5.1tTotal Earnings: DKK 322.2bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.4x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 16.7x which is lower than its 3-year average PE of 22.4x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 8.6% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market2.91%
Consumer Discretionary7.29%
Healthcare7.00%
Consumer Staples3.28%
Materials2.97%
Telecom0.63%
Industrials-0.59%
Financials-1.30%
Real Estate-1.58%
Utilities-2.36%
Tech-2.98%
Energy-7.34%
Sector PE
  • Investors favour the Materials sector the most for future growth even though it's trading below its 3-year average PE ratio of 59.2x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 15.0%, which is higher than its past year's earnings growth of 11.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings decline of 25% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 36% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 317.958.5%
+DKK 110.7b		-27.3%PE11.5xHealthcare
DSV DSVDKK 1.55k1.7%
+DKK 6.3b		1.5%PE51.4xIndustrials
PNDORA PandoraDKK 743.2013.3%
+DKK 6.2b		-33.1%PE10.3xConsumer Discretionary
NSIS B NovozymesDKK 407.203.3%
+DKK 6.1b		-11.8%PE42.5xMaterials
MAERSK B A.P. Møller - MærskDKK 15.94k2.2%
+DKK 5.1b		31.6%PE21.7xIndustrials
See more

Market Insights

Header cover image
Yield measures a moment. A decade of raising it measures the business: durable earnings, a clean balance sheet, and management disciplined enough to keep it.
Continue reading
Watt's left in the overcrowded power trade?

Latest News

MAERSK B
DKK 15,940.00
A.P. Møller - Mærsk
7D
2.2%
1Y
31.6%
FLS
DKK 465.20
FLSmidth
7D
-9.0%
1Y
19.3%
Narrative Update • Jun 26

FLS: Share Buy-Back Programme Will Support Re-Rating Potential

The analyst fair value estimate for FLSmidth has been raised from DKK 550 to DKK 700, with analysts pointing to higher price targets across the Street and supporting arguments related to revenue growth, improving margins and a lower assumed future P/E multiple. Analyst Commentary Recent research on FLSmidth shows a cluster of upgrades and higher price targets, which points to a generally constructive tone from bullish analysts around the stock's execution and valuation.
TRMD A
DKK 177.90
TORM
7D
-7.3%
1Y
60.6%
Narrative Update • Jun 26

TRMD A: Higher Q2 Margins And Major Shareholder Will Drive Future Repricing

TORM's updated analyst price target has shifted from about DKK 171 to roughly DKK 255, with analysts citing that the previously highlighted strong Q2 and adjusted expectations for profit margins and valuation multiples are now more fully reflected in the shares. Analyst Commentary Recent commentary around TORM highlights a split view, with some analysts arguing that the strong Q2 performance is now largely reflected in the stock price.
NSIS B
DKK 407.20
Novozymes
7D
3.3%
1Y
-11.8%
Narrative Update • Jun 26

NSIS B: Consumer Ingredients And Probiotics Expansion Will Support Premium Multiple

Analysts have nudged the fair value estimate for Novozymes (Novonesis) slightly lower to DKK 548.58 from about DKK 560, reflecting a blend of trimmed Street price targets around DKK 552 and DKK 460, as well as updated assumptions for revenue growth, profit margins and a more conservative future P/E of 34x. Analyst Commentary Recent Street research on Novozymes reflects a mix of fine tuning on price targets and ratings, with bullish analysts focusing on the company’s positioning in consumer ingredients and its ability to support premium valuation metrics.
ROCK B
DKK 213.80
Rockwool
7D
-2.7%
1Y
-28.0%
Narrative Update • Jun 25

ROCK B: Higher 2026 Margin Outlook Will Expose Execution Risk

The analyst price target for Rockwool has moved slightly higher to DKK 230. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples that align with recent analyst research and rating changes.
DSV
DKK 1,553.50
DSV
7D
1.7%
1Y
1.5%
Narrative Update • Jun 25

DSV: Logistics Expansion And Automation Will Support Future Repricing Potential

The analyst price target for DSV has been nudged higher to reflect a fair value increase of about DKK 12 to DKK 2,059.80. Analysts attribute this to incremental adjustments in revenue growth assumptions, a slightly lower discount rate and updated forward P/E expectations, alongside a series of recent price target raises across the Street, including moves up to DKK 2,150 and DKK 2,200.
GMAB
DKK 1,702.00
Genmab
7D
4.0%
1Y
30.0%
Narrative Update • Jun 25

GMAB: Upcoming Oncology Readouts Will Test Commercial Model And Earnings Resilience

Genmab's analyst price targets have been revised lower, with one recent DKK target cut from DKK 48 to DKK 40, as analysts factor in updated assumptions for revenue growth, margins and long term P/E. They still point to the company's shift toward a commercially driven platform and upcoming data readouts for Epkinly, Rina-S and petosemtamab as key drivers in the story.
NOVO B
DKK 317.95
Novo Nordisk
7D
8.5%
1Y
-27.3%
DEMANT
DKK 266.00
Demant
7D
7.3%
1Y
0.7%
Narrative Update • Jun 23

DEMANT: Fair Value View Balances Growth Inflection Hopes With Execution Risks

Analysts have lifted their price expectations for Demant, with the consensus fair value estimate moving from DKK 240.32 to DKK 251.11. Recent research points to a higher price target range supported by updated views on growth, profitability and future P/E multiples.
VWS
DKK 172.50
Vestas Wind Systems
7D
-5.6%
1Y
67.1%
Narrative Update • Jun 22

VWS: Balanced Order Momentum And Mixed Rating Shifts Will Shape Execution Risks

The analyst-derived fair value estimate for Vestas Wind Systems has shifted modestly higher to DKK 187.94. This reflects a rebalanced view of growth, margins and discount rate assumptions in line with recent price target moves and rating changes from Street analysts.
NKT
DKK 939.00
NKT
7D
-9.1%
1Y
81.4%
Analysis Article • Jun 21

NKT (CPSE:NKT) Stock Could Be 37% Below Fair Value After Champlain Hudson Milestone

NKT’s Champlain Hudson milestone and why it matters for investors NKT (CPSE:NKT) drew fresh attention after joining customers and partners to inaugurate the Champlain Hudson Power Express, a 400 kV HVDC transmission line carrying Canadian hydropower into New York City. The project was awarded in 2022 and is now in commercial operation. It links Québec to New York City across more than 600 km and can transmit up to 1,250 megawatts of renewable power, enough to cover an estimated 20% of the...
PNDORA
DKK 743.20
Pandora
7D
13.3%
1Y
-33.1%
Narrative Update • Jun 18

PNDORA: Lower Discount Rate And Margin Outlook Will Sustain Bearish Earnings View

Pandora's analyst price target has been revised from DKK 365 to DKK 380, with analysts pointing to changes in fair value assumptions, discount rate, revenue growth, profit margin and future P/E expectations as key drivers of the update. What’s in the News for Pandora Pandora reaffirmed its earnings guidance for fiscal year 2026, indicating an expected EBIT margin in the range of 21% to 22%.
CARL B
DKK 870.00
Carlsberg
7D
4.1%
1Y
-2.2%
Narrative Update • Jun 16

CARL B: Expanded Bottling Agreements Will Support Future Share Price Rerating

Analysts have made a modest downward adjustment to the Carlsberg price target in DKK, reflecting updated expectations for revenue growth, profit margins and future P/E, even as recent research includes both a DKK 30 target cut and a more positive stance from some firms. Analyst Commentary Recent Street research on Carlsberg highlights a mix of cautious price target trims and a more positive stance from some bullish analysts.
JYSK
DKK 935.00
Jyske Bank
7D
-1.6%
1Y
44.3%
Narrative Update • Jun 16

JYSK: Share Repurchases And Capital Changes Will Steady Future Share Price

Analysts have nudged their price target for Jyske Bank slightly higher, with fair value moving from DKK 946.00 to DKK 950.00, citing small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions. What’s in the News for Jyske Bank Jyske Bank is progressing with its 2026 share repurchase programme, which runs from 5 February 2026 to 29 January 2027 and targets up to DKK 3b in share buybacks, according to recent disclosures.
DANSKE
DKK 344.70
Danske Bank
7D
-2.1%
1Y
32.8%
Narrative Update • Jun 16

DANSKE: Future Share Returns Will Hinge On Delivering Capital Returns

Danske Bank's analyst price target has moved higher to DKK 368. The change is supported by analysts citing updated expectations around revenue growth, profitability and valuation multiples reflected in the refreshed fair value estimate.
ORSTED
DKK 144.70
Ørsted
7D
-2.4%
1Y
-48.8%